Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
97%
Transforming Growth Factor-β
79%
Fibrosis
79%
Skeletal muscle
72%
Sarcopenia
66%
Skeletal muscle Atrophy
60%
Muscle Strength
58%
Nonalcoholic Steatohepatitis
56%
Duchenne muscular Dystrophy
49%
Angiotensin-(1-7)
49%
CCN2
48%
Oxidative Stress
45%
Mdx Mice
41%
Chronic Liver Disease
38%
Liver
38%
Bile Acids
37%
Metabolic-associated Fatty Liver Disease (MAFLD)
35%
Connective Tissue Growth Factor
33%
Muscular Dystrophy
32%
Dystrophic muscle
32%
Ubiquitin-proteasome System
31%
Dystrophic
30%
Profibrotic
28%
Skeletal muscle Cells
27%
Myosin Heavy Chain (MyHC)
27%
Hepatocytes
26%
Andrographolide
26%
Mouse Model
25%
High-fat Diet
25%
TGR5
24%
Protein Level
24%
Inflammation
24%
Muscle Fiber
24%
Muscle Wasting
23%
Steatosis
21%
Liver Disease Progression
21%
Mineralocorticoid Receptor
21%
Muscle Mass
20%
Diet-induced
20%
Myonuclear Apoptosis
19%
Fibroblasts
19%
Decorin
19%
Mas Receptor
19%
Hepatic Stellate Cells
18%
Fatty Acids
18%
Fatty Acid Composition
17%
Magnetic Resonance Spectroscopy
17%
Chemical Hypoxia
17%
Deoxycholic Acid
17%
Metabolic
17%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Muscle Atrophy
77%
Fibrosis
64%
Transforming Growth Factor Beta
64%
Sarcopenia
62%
angiotensin[1-7]
51%
Inflammation
40%
Receptor
40%
Bile Acid
37%
Reactive Oxygen Metabolite
31%
Liver Disease
30%
Fatty Acid
30%
Disease
30%
Chronic Liver Disease
30%
Muscular Dystrophy
29%
Duchenne Muscular Dystrophy
28%
Myosin Heavy Chain
27%
Connective Tissue Growth Factor
26%
Andrographolide
26%
Somatomedin C
24%
TGF-Beta
20%
Steatosis
18%
Experimental Steatohepatitis
18%
Mouse Model
18%
Growth Hormone
17%
Cholic Acid
17%
Deoxycholic Acid
17%
Ethanol
17%
Hypoxia
17%
Muscle Disease
15%
Angiotensin
15%
Inflammasome
14%
Fatty Liver
14%
Renin
14%
Triacylglycerol
14%
Myofibrosis
14%
Disease Exacerbation
13%
Proteasome
13%
Ubiquitin
13%
Acetylcysteine
11%
Liver Cell Carcinoma
11%
Glucocorticoid
10%
Apocynin
10%
Prevalence
10%
Cholestasis
10%
Injury
10%
Biological Marker
10%
Membrane Receptor
10%
Dipeptidyl Carboxypeptidase
9%
Cancer Growth Factor
9%
Medicine and Dentistry
Nonalcoholic Fatty Liver
95%
Skeletal Muscle
78%
Sarcopenia
56%
Fibrosis
52%
Transforming Growth Factor Beta
51%
Oxidative Stress
40%
Chronic Liver Disease
35%
Disease
33%
Muscle Atrophy
30%
Muscular Dystrophy
29%
Duchenne Muscular Dystrophy
29%
Connective Tissue Growth Factor
28%
Bile Acid
26%
Liver Disease
25%
Muscle Strength
25%
Skeletal Muscle Atrophy
24%
Metabolic Dysfunction-Associated Steatotic Liver Disease
23%
High Fat Food
23%
Programmed Cell Death
23%
Fatty Liver
21%
Steatohepatitis
21%
Reactive Oxygen Species
19%
Cell Therapy
18%
Fatty Acid
18%
Mineralocorticoid Receptor
17%
Hepatic Stellate Cell
17%
NMR Spectroscopy
17%
Signal Transduction
16%
Hepatocyte
16%
Hepatocellular Carcinoma
14%
Somatomedin C
14%
Mitochondrial Disorder
13%
Liver Cirrhosis
12%
Prevalence
12%
Acetylcysteine
11%
Renin Angiotensin Aldosterone System
11%
Heavy Meromyosin
11%
Muscle Disease
11%
Proteasome
11%
Ubiquitin
11%
Cholestasis
10%
Biological Marker
10%
Diabetes
10%
Innate Immunity
10%
TGF-Beta
10%
Side Effect
10%
Malignant Neoplasm
10%
Non-Alcoholic Fatty Liver Disease
10%
Drug Therapy
9%
Steatosis
9%
